Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mavacamten in Symptomatic Non-Obstructive HCM (MAVERICK-HCM)
NCT03442764Phase 2Completed
- Sponsor
- MyoKardia
- Start
- Mar 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mavacamten in hypertrophic cardiomyopathy (HCM), sponsored by MyoKardia. Started Mar 2018; status: completed.
02
Drugs
mavacamten
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT03442764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03442764.